跳至主要内容
临床试验/CTRI/2020/11/028934
CTRI/2020/11/028934尚未招募未知

Intermittent phototherapy versus continuous phototherapy for treatment of neonatal hyperbilirubinemia: A randomized control trial

Defence Research and Development Organization0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All late preterm (>= 35 weeks) and term neonates who need phototherapy for treatment of neonatal hyperbilirubinemia as per AAP guidelines (Low and Medium risk groups) either during birth hospitalization or readmitted after discharge in the first two weeks

排除标准

  • High risk group as per AAP Guidelines
  • Onset of jaundice in the first 24 hours after birth
  • TSB in the exchange range at enrollment
  • Hemolytic jaundice (positive direct coombs test, evidence of hemolysis on peripheral blood smear or reticulocyte count > 6%)
  • Any neonate admitted in NICU
  • Major congenital malformations
  • Direct hyperbilirubinemia (direct bilirubin > 15% of total or > 1.0 mg/dl)

研究者

发起方
Defence Research and Development Organization

相似试验